Recursion Pharmaceuticals
RXRX
RXRX
158 hedge funds and large institutions have $953M invested in Recursion Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 43 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
–
Holders Change %
0%
% of All Funds
2.49%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
26
Increased
58
Reduced
43
Closed
26
Calls
$1.04M
Puts
$765K
Net Calls
+$272K
Net Calls Change
+$22K
Top Buyers
Top Sellers
| 1 |
LCM
Laurion Capital Management
New York
|
$23.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
$21.4M |
| 3 |
State Street
Boston,
Massachusetts
|
$42.6M |
| 4 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
$6.59M |
| 5 |
Millennium Management
New York
|
$0 |
